NDAORALTABLET
Approved
Aug 2010
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
20
Data completeness
7/8 — Comprehensive
ELLA (ulipristal acetate) by Teva is occur, ella postpones follicular rupture. First approved in 2010.
Drug data last refreshed 3h ago · AI intelligence enriched 4d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ELLA (ulipristal acetate) is an oral emergency contraceptive tablet approved in 2010 that works by inhibiting or delaying ovulation, with potential secondary effects on endometrial alterations that may affect implantation. It is indicated for emergency contraception and represents a selective progesterone receptor modulator mechanism. The drug is taken as a single oral dose within 120 hours of unprotected intercourse.
$0.741MPart D
Peak3.7 years to LOEProduct is in peak lifecycle with modest Part D utilization; commercial team likely focused on defensive strategies and niche market penetration rather than growth expansion.
Mechanism of Action
occur, ella postpones follicular rupture. The likely primary mechanism of action of ulipristal acetate for emergency contraception is therefore inhibition or delay of ovulation; however, alterations to the endometrium that may affect implantation may also contribute to efficacy.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
Started Sep 2026
110 enrolled
Asthma
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
Started Sep 2026
250 enrolled
Heart FailureCardiogenic ShockReduced Ejection Fraction Heart Failure
China Treatment Trial for Tumor in Sellar Region With Unruptured Intracranial Aneurysm
Started Sep 2026
608 enrolled
Unruptured Intracranial AneurysmsPituitary Neuroendocrine TumorCraniopharyngioma+6 more
Mammogram Pretreatment With Ulipristal Acetate
Started Aug 2026
26 enrolled
Mammography ScreeningBreast Density
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age
Started Aug 2026
1,860 enrolled
MeaslesMumpsRubella+2 more
Worked on ELLA at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.